Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Recruiting 2Completed 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4Gastrointestinal 1

Conditions

Breast Neoplasms 6Lung Neoplasms 5Colorectal Neoplasms 5Prostatic Neoplasms 4Motor Activity 3Hodgkin Disease 2Hematopoietic and Lymphoid System Neoplasm 2Carcinoma, Non-Small-Cell Lung 2Urinary Bladder Neoplasms 1Stress Disorders, Post-Traumatic 1Sleep Wake Disorders 1Sedentary Behavior 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Pathologically Proven Gastrointestinal Malignancy 1Obesity 1Neoplasms 1Neoplasm, Residual 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Malignant Solid Neoplasm 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Hairy Cell 1Leukemia 1Insulin Resistance 1Inflammatory Breast Neoplasms 1Hematopoietic and Lymphatic System Neoplasm 1

Interventions

Docetaxel 277Prednisone 236enzalutamide 175Leuprolide 172Radiotherapy 164Abiraterone Acetate 153Magnetic Resonance Spectroscopy 147bicalutamide 137Goserelin 134Androgen Antagonists 111Radiosurgery 101acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 100apalutamide 78abiraterone 75gallium 68 PSMA-11 74Specimen Handling 67Gonadotropin-Releasing Hormone 58darolutamide 56Radiation 56Triptorelin Pamoate 53cabazitaxel 49Zoledronic Acid 49pembrolizumab 48Radiotherapy, Intensity-Modulated 47Flutamide 47Brachytherapy 47luprolide acetate gel depot 46Standard of Care 45Carboplatin 44Estramustine 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Prostatic Neoplasms × Exercise Test × Clear all
NCT06330805 2026-03-09

Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
70 enrolled
Genitourinary

Prostatic Neoplasms

NCT06016725 2026-01-02

E-PROOF

Ohio State University Comprehensive Cancer Center

Phase NA Completed
75 enrolled 27 charts
GastrointestinalGenitourinary

Prostatic Neoplasms, Colorectal Neoplasms

NCT06500169 2025-12-04

GREENS

University of Southern California

Phase NA Recruiting
20 enrolled
Genitourinary

Prostatic Neoplasms

NCT02435472 2025-04-11

ASX

University of California, San Francisco

Phase NA Completed
104 enrolled
Genitourinary

Motor Activity, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡